The Chronic Lymphocytic Leukemia Epigenome
Hematology/Oncology Clinics of North America · 2025
DOI: 10.1016/j.hoc.2025.05.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2025. Verfasst von Antonio Perez-Castro und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, …. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Epigenesis, Genetic, DNA Methylation, Epigenome. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Cancer Society, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
This review explores how epigenetic information, and in particular DNA methylation-based "epitypes," enhances our understanding of chronic lymphocytic leukemia (CLL) biology and prognosis. Epitypes correlate with B-cell maturation stages and outperform traditional biomarkers like immunoglobulin heavy chain variable region mutation status in predicting outcomes. The stability and specificity of CLL epigenetic patterns offer insights into disease history, risk stratification, and treatment response, even amid evolving therapeutic landscape. Emerging epigenetic signatures, including proliferative indices, further refine patient classification and outcome prediction, underscoring the potential clinical utility of integrating epigenetic data in CLL management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA.
- Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine, The Medical University of South Carolina, Charleston, SC 29425-9080, USA.
- The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA; Division of Hematology, Department of Internal Medicine, The…
Förderung
- NCI NIH HHS
- American Cancer Society
- National Institutes of Health National Cancer Institute
- National Institutes of Health
Zitieren
APA
Perez-Castro, A., Abruzzo, L. V., & Oakes, C. C. (2025). The Chronic Lymphocytic Leukemia Epigenome. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2025.05.005
Vancouver
Perez-Castro A, Abruzzo LV, Oakes CC. The Chronic Lymphocytic Leukemia Epigenome. Hematology/Oncology Clinics of North America. 2025. doi:10.1016/j.hoc.2025.05.005
BibTeX
@article{PerezCastro2025,
author = {Perez-Castro, Antonio and Abruzzo, Lynne V and Oakes, Christopher C},
title = {The Chronic Lymphocytic Leukemia Epigenome},
journal = {Hematology/Oncology Clinics of North America},
year = {2025},
doi = {10.1016/j.hoc.2025.05.005}
}
EUVIMED